Related Experiment Video
Updated: Sep 21, 2025
Multimodality Diagnosis of Mesenteric Ischemia
Published on: July 21, 2023
Arterial mesenteric thrombosis in COVID-19 positive patient: A case report
Zinaida Tital Jndoyan1, Suren Agho Stepanyan2, Ani Roland Harutyunyan3
1Yerevan State Medical University after M. Heratsi, Head of Department of Propaedeutics of internal medicine, Yerevan, Republic of Armenia. jndoyanzinaida@rambler.ru.
Insights
COVID-19 can cause hypercoagulation, leading to arterial ischemic events like mesenterial thrombosis. This heightened blood clot risk is a serious complication that increases mortality in patients with coronavirus disease 2019.
Area of Science:
- Medicine
- Infectious Diseases
- Cardiology
Background:
- Coronavirus disease 2019 (COVID-19) is a global pandemic with significant mortality.
- Coagulopathy is a recognized complication of severe COVID-19.
- Arterial ischemic events are increasingly reported in COVID-19 patients.
Observation:
- This clinical case highlights a patient with COVID-19 who developed mesenterial thrombosis.
- Mesenterial thrombosis occurred as a late complication of the disease.
- The patient exhibited signs of hypercoagulation.
Findings:
- Hypercoagulation plays a crucial role in the clinical presentation of COVID-19.
- Increased blood clot formation elevates the risk of arterial thrombosis.
- Mesenterial thrombosis represents a severe, late-stage complication of COVID-19.
Implications:
- Understanding hypercoagulation in COVID-19 is vital for risk stratification.
- Early identification and management of coagulopathy may improve patient outcomes.
- This case underscores the need for vigilance regarding thrombotic complications in COVID-19 survivors.
Abstract:
COVID-19 has resulted in the death of a number of people around the world. Complications of COVID-19 including coagulopathy may contribute to the development of arterial ischemic events. Mesenterial thrombosis is a late complication of the disease. This clinical case presented the role of hypercoagulation in the clinical picture of the COVID-19 patients, which increased the risk of death.
